Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110794 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-03 | 2020-05-08 | 110797 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110800 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110803 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110806 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-05-01 | 111803 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-04-10 | 2020-05-14 | 111807 |
TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111810 |
TEVA-ATAZANAVIR | 300MG | CAPSULE | Resolved | 2020-04-10 | 2020-07-23 | 111813 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2020-04-10 | 2020-04-16 | 111816 |
TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2020-04-10 | 2020-04-16 | 111819 |
TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-10 | 2020-05-29 | 111823 |
TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-10 | 2020-06-04 | 111826 |
NOVO-GESIC FORTE | 500MG | TABLET | Resolved | 2020-04-10 | 2020-06-04 | 111829 |
TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-04-23 | 111832 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2020-04-10 | 2020-05-21 | 111835 |
ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-04-10 | 2020-09-03 | 111846 |
TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-04-10 | 2020-04-23 | 111851 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |